TKPHF News and Press, Takeda Pharmaceutical Co Ltd From 07/05/20

Quick Take Nkarta ( NKTX ) intends to raise $150 million in an IPO of its common stock, according to an amended registration statement . The company is advancing a pipeline of drug candidates for the treatment of blood and other cancer indications. NKTX is still at preclinical stage of ...

Takeda Reports Positive Data for Late Stage Multiple Myeloma Trial Takeda Pharmaceutical Company Limited (TAK) announced data from its Phase 3 clinical trial of single-agent oral NINLARO as well as from the US MM-6 study. NINLARO, in combination with lenalidomide and dexamethasone, is curr...

The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction with this Read more ...

There are many levels to the coronavirus pandemic and a massive effort is underway to find a vaccine and treatments. Genetic Engineering News summarised 161+ candidates. The US clinical trials website indicates 1,915 trials underway using the keyword COVID-19 (June 3, 2020). The common c...

This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 05/15/2020. Please visit our Tracking Larry Robbins’ Glenview Capital Manage...

This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking John Paulson’s Paulson & Co...

Takeda Receives FDA Approval for Brigatinib Takeda Pharmaceutical Company Limited ( TAK ) announced that the FDA has given a green signal for its ALUNBRIG (Brigatinib) in adult patients suffering from anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer. The lab...

Takeda Pharmaceutical Company Limited (TKPHF) Q4 2019 Earnings Conference Call May 13, 2020, 08:30 AM ET Company Participants Takashi Okubo - IR Christophe Weber - President and CEO Andrew Plump - President of R&D Costa Saroukos - CFO Ramona Sequeira - President of USBU a...

The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction with their 2019 Q4 earnings Read more ...

Quick Take ADC Therapeutics ( ADCT ) intends to raise $125 million from the sale of its common stock, per an amended registration statement . The company is advancing a pipeline of drug candidates for the treatment of blood cancers and solid tumors. ADCT is making a new attempt to go pu...